Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Surge
Surge provides a clinical test that identifies surgical patients at high risk of postoperative infections so care teams can intervene earlier and tailor discharge and monitoring. The company converts…
Surge
Surge provides a clinical test that identifies surgical patients at high risk of postoperative infections so care teams can intervene earlier and tailor discharge and monitoring. The company converts…
TL;DR
Product: PreCyte — perioperative test that predicts postoperative infection risk using single-cell/multiomic immune profiling
Core tech: Stabl biological fingerprinting algorithm + machine-learning models
Business model: Precision-medicine B2B SaaS / lab offering for hospitals and surgical teams
Recent funding: Seed round (Mar 27, 2024) — €7.5M led by Eurazeo
Company Overview
Problem Domain
Perioperative risk stratification and prevention of postoperative infections and complications
Founded
2022
Industry
Biotechnology
Tech Stack
Funding Track Record
€7,500,000
Round included participation from Kima, Teampact, MH Innov', Boutique Venture, HCVC, and 50 Partners Santé; complemented by Bpifrance support
Investor Signal
“Participation from European VC firms and healthtech investors including Eurazeo, Kima Ventures, Teampact, HCVC, Boutique Venture, 50 Partners, and support from Bpifrance”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
80,000+
Open Roles
4,300+
New This Week